SCHEMBL976837

SCHEMBL976837

C[C@@H](c1ccccc1)N1CCCC1C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.49
KDM4E B2RXH2 1/20 0.45
CYP2D6 P10635 3/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
OPRL1 P41146 1/20 0.41
ELANE P08246 2/20 0.41
DPP4 P27487 2/20 0.40
POLB P06746 1/20 0.40
CHRM2 P08172 3/20 0.40
CHRM4 P08173 3/20 0.40
CHRM5 P08912 3/20 0.40
CHRM1 P11229 3/20 0.40
CHRM3 P20309 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
AR P10275 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7313734 1.00 KMT2A (0.49) KMT2AKDM4ECYP2D6HTTTDP1
SCHEMBL7959886 0.88 KDM4E (0.47) KMT2AKDM4ECYP2D6HTTPOLB
SCHEMBL7973302 0.88 KDM4E (0.47) KMT2AKDM4ECYP2D6HTTPOLB
SCHEMBL7973454 0.88 KDM4E (0.47) KMT2AKDM4ECYP2D6HTTPOLB
SCHEMBL7973306 0.88 KDM4E (0.47) KMT2AKDM4ECYP2D6HTTPOLB
SCHEMBL28860925 0.88 KDM4E (0.47) KMT2AKDM4ECYP2D6HTTPOLB
SCHEMBL7976128 0.88 KDM4E (0.47) KMT2AKDM4ECYP2D6HTTPOLB
SCHEMBL7959881 0.88 KDM4E (0.47) KMT2AKDM4ECYP2D6HTTPOLB
SCHEMBL24359262 0.85 KMT2A (0.45) KMT2AKDM4ECYP2D6HTTTDP1
SCHEMBL7305362 0.85 KMT2A (0.45) KMT2AKDM4ECYP2D6HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448935-A1 SUBSTITUTED 2-CARBOXAMIDE CYCLOAMINO UREAS Novartis AG (CH) 2012-05-09 EP disclosed
WO-2011000905-A1 SUBSTITUTED 2-CARBOXAMIDE CYCLOAMINO UREAS NOVARTIS AG (CH) 2011-01-06 WO disclosed